HEADER HYDROLASE 20-JUN-17 5OA5 TITLE CELLOBIOHYDROLASE I (CEL7A) FROM HYPOCREA JECORINA WITH IMPROVED TITLE 2 THERMAL STABILITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXOGLUCANASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 18-451; COMPND 5 SYNONYM: 1,4-BETA-CELLOBIOHYDROLASE,EXOCELLOBIOHYDROLASE I,CBHI, COMPND 6 EXOGLUCANASE I; COMPND 7 EC: 3.2.1.91; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HYPOCREA JECORINA; SOURCE 3 ORGANISM_TAXID: 51453; SOURCE 4 GENE: CBH1; SOURCE 5 EXPRESSION_SYSTEM: ASPERGILLUS AWAMORI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 105351; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: AP4; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PRAXDES; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRAXDES KEYWDS HYDROLASE, CELLULASE, PROTEIN ENGINEERING EXPDTA X-RAY DIFFRACTION AUTHOR F.GOEDEGEBUUR,H.HANSSON,S.KARKEHABADI,N.MIKKELSEN,J.STAHLBERG, AUTHOR 2 M.SANDGREN REVDAT 9 23-OCT-24 5OA5 1 REMARK REVDAT 8 07-FEB-24 5OA5 1 REMARK REVDAT 7 08-MAR-23 5OA5 1 SPRSDE REVDAT 6 30-MAR-22 5OA5 1 HETSYN REVDAT 5 29-JUL-20 5OA5 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 11-MAR-20 5OA5 1 REMARK SEQRES REVDAT 3 01-NOV-17 5OA5 1 JRNL REVDAT 2 13-SEP-17 5OA5 1 JRNL REVDAT 1 06-SEP-17 5OA5 0 JRNL AUTH F.GOEDEGEBUUR,L.DANKMEYER,P.GUALFETTI,S.KARKEHABADI, JRNL AUTH 2 H.HANSSON,S.JANA,V.HUYNH,B.R.KELEMEN,P.KRUITHOF,E.A.LARENAS, JRNL AUTH 3 P.J.M.TEUNISSEN,J.STAHLBERG,C.M.PAYNE,C.MITCHINSON, JRNL AUTH 4 M.SANDGREN JRNL TITL IMPROVING THE THERMAL STABILITY OF CELLOBIOHYDROLASE CEL7A JRNL TITL 2 FROM HYPOCREA JECORINA BY DIRECTED EVOLUTION. JRNL REF J. BIOL. CHEM. V. 292 17418 2017 JRNL REFN ESSN 1083-351X JRNL PMID 28860192 JRNL DOI 10.1074/JBC.M117.803270 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 53986 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2882 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3978 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.64 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE SET COUNT : 183 REMARK 3 BIN FREE R VALUE : 0.3030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6480 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 546 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.96000 REMARK 3 B22 (A**2) : 2.48000 REMARK 3 B33 (A**2) : -1.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.226 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.190 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.130 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.952 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6777 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9261 ; 1.309 ; 1.952 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 872 ; 6.424 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 296 ;33.115 ;25.676 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 958 ;13.235 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;18.973 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 996 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5318 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3479 ; 0.949 ; 1.673 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4348 ; 1.666 ; 2.504 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3298 ; 1.098 ; 1.764 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 10782 ; 4.353 ;14.570 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 5OA5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1200005422. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : HORIZONTALLY DIFFRACTING SI REMARK 200 (111) MONOCHROMATOR REMARK 200 OPTICS : PT COATED MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56990 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 41.160 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.710 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.73 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.860 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 2V3I REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25.5% POLYETHYLENE GLYCOL (PEG) 4000, REMARK 280 0.17 M AMSO4 AND 15% GLYCEROL, PH 6.0, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 51.47000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.05000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 51.47000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.05000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 87 113.81 -162.11 REMARK 500 SER A 99 -126.96 -118.11 REMARK 500 ASN A 188 53.60 -95.55 REMARK 500 SER A 248 149.21 171.80 REMARK 500 ARG A 251 -36.00 -37.81 REMARK 500 SER A 379 -155.38 -146.86 REMARK 500 ASN B 54 24.93 -140.58 REMARK 500 PHE B 95 -71.61 -76.82 REMARK 500 SER B 99 -124.53 -119.59 REMARK 500 ASN B 188 52.07 -96.39 REMARK 500 SER B 248 152.67 158.32 REMARK 500 MET B 374 16.53 59.94 REMARK 500 SER B 379 -154.37 -134.91 REMARK 500 SER B 387 11.09 -66.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 877 DISTANCE = 6.24 ANGSTROMS REMARK 999 REMARK 999 SEQUENCE REMARK 999 ENGINEERED ENZYME WITH 17 INTRODUCED MUTATIONS. NATURALLY REMARK 999 OCCURRING PYROGLUTAMATE AT THE N-TERMINUS. DBREF 5OA5 A 2 434 UNP P62694 GUX1_HYPJE 19 451 DBREF 5OA5 B 2 434 UNP P62694 GUX1_HYPJE 19 451 SEQADV 5OA5 PRO A 8 UNP P62694 SER 25 ENGINEERED MUTATION SEQADV 5OA5 ILE A 41 UNP P62694 THR 58 ENGINEERED MUTATION SEQADV 5OA5 SER A 49 UNP P62694 ASN 66 ENGINEERED MUTATION SEQADV 5OA5 THR A 68 UNP P62694 ALA 85 ENGINEERED MUTATION SEQADV 5OA5 ASP A 89 UNP P62694 ASN 106 ENGINEERED MUTATION SEQADV 5OA5 THR A 92 UNP P62694 SER 109 ENGINEERED MUTATION SEQADV 5OA5 ASN A 113 UNP P62694 SER 130 ENGINEERED MUTATION SEQADV 5OA5 THR A 196 UNP P62694 SER 213 ENGINEERED MUTATION SEQADV 5OA5 LEU A 227 UNP P62694 PRO 244 ENGINEERED MUTATION SEQADV 5OA5 LYS A 249 UNP P62694 ASP 266 ENGINEERED MUTATION SEQADV 5OA5 PRO A 255 UNP P62694 THR 272 ENGINEERED MUTATION SEQADV 5OA5 PRO A 278 UNP P62694 SER 295 ENGINEERED MUTATION SEQADV 5OA5 LYS A 295 UNP P62694 GLU 312 ENGINEERED MUTATION SEQADV 5OA5 PRO A 296 UNP P62694 THR 313 ENGINEERED MUTATION SEQADV 5OA5 TYR A 332 UNP P62694 THR 349 ENGINEERED MUTATION SEQADV 5OA5 ASP A 403 UNP P62694 VAL 420 ENGINEERED MUTATION SEQADV 5OA5 PHE A 411 UNP P62694 SER 428 ENGINEERED MUTATION SEQADV 5OA5 PRO B 8 UNP P62694 SER 25 ENGINEERED MUTATION SEQADV 5OA5 ILE B 41 UNP P62694 THR 58 ENGINEERED MUTATION SEQADV 5OA5 SER B 49 UNP P62694 ASN 66 ENGINEERED MUTATION SEQADV 5OA5 THR B 68 UNP P62694 ALA 85 ENGINEERED MUTATION SEQADV 5OA5 ASP B 89 UNP P62694 ASN 106 ENGINEERED MUTATION SEQADV 5OA5 THR B 92 UNP P62694 SER 109 ENGINEERED MUTATION SEQADV 5OA5 ASN B 113 UNP P62694 SER 130 ENGINEERED MUTATION SEQADV 5OA5 THR B 196 UNP P62694 SER 213 ENGINEERED MUTATION SEQADV 5OA5 LEU B 227 UNP P62694 PRO 244 ENGINEERED MUTATION SEQADV 5OA5 LYS B 249 UNP P62694 ASP 266 ENGINEERED MUTATION SEQADV 5OA5 PRO B 255 UNP P62694 THR 272 ENGINEERED MUTATION SEQADV 5OA5 PRO B 278 UNP P62694 SER 295 ENGINEERED MUTATION SEQADV 5OA5 LYS B 295 UNP P62694 GLU 312 ENGINEERED MUTATION SEQADV 5OA5 PRO B 296 UNP P62694 THR 313 ENGINEERED MUTATION SEQADV 5OA5 TYR B 332 UNP P62694 THR 349 ENGINEERED MUTATION SEQADV 5OA5 ASP B 403 UNP P62694 VAL 420 ENGINEERED MUTATION SEQADV 5OA5 PHE B 411 UNP P62694 SER 428 ENGINEERED MUTATION SEQRES 1 A 434 PCA SER ALA CYS THR LEU GLN PRO GLU THR HIS PRO PRO SEQRES 2 A 434 LEU THR TRP GLN LYS CYS SER SER GLY GLY THR CYS THR SEQRES 3 A 434 GLN GLN THR GLY SER VAL VAL ILE ASP ALA ASN TRP ARG SEQRES 4 A 434 TRP ILE HIS ALA THR ASN SER SER THR SER CYS TYR ASP SEQRES 5 A 434 GLY ASN THR TRP SER SER THR LEU CYS PRO ASP ASN GLU SEQRES 6 A 434 THR CYS THR LYS ASN CYS CYS LEU ASP GLY ALA ALA TYR SEQRES 7 A 434 ALA SER THR TYR GLY VAL THR THR SER GLY ASP SER LEU SEQRES 8 A 434 THR ILE GLY PHE VAL THR GLN SER ALA GLN LYS ASN VAL SEQRES 9 A 434 GLY ALA ARG LEU TYR LEU MET ALA ASN ASP THR THR TYR SEQRES 10 A 434 GLN GLU PHE THR LEU LEU GLY ASN GLU PHE SER PHE ASP SEQRES 11 A 434 VAL ASP VAL SER GLN LEU PRO CYS GLY LEU ASN GLY ALA SEQRES 12 A 434 LEU TYR PHE VAL SER MET ASP ALA ASP GLY GLY VAL SER SEQRES 13 A 434 LYS TYR PRO THR ASN THR ALA GLY ALA LYS TYR GLY THR SEQRES 14 A 434 GLY TYR CYS ASP SER GLN CYS PRO ARG ASP LEU LYS PHE SEQRES 15 A 434 ILE ASN GLY GLN ALA ASN VAL GLU GLY TRP GLU PRO SER SEQRES 16 A 434 THR ASN ASN ALA ASN THR GLY ILE GLY GLY HIS GLY SER SEQRES 17 A 434 CYS CYS SER GLU MET ASP ILE TRP GLU ALA ASN SER ILE SEQRES 18 A 434 SER GLU ALA LEU THR LEU HIS PRO CYS THR THR VAL GLY SEQRES 19 A 434 GLN GLU ILE CYS GLU GLY ASP GLY CYS GLY GLY THR TYR SEQRES 20 A 434 SER LYS ASN ARG TYR GLY GLY PRO CYS ASP PRO ASP GLY SEQRES 21 A 434 CYS ASP TRP ASN PRO TYR ARG LEU GLY ASN THR SER PHE SEQRES 22 A 434 TYR GLY PRO GLY PRO SER PHE THR LEU ASP THR THR LYS SEQRES 23 A 434 LYS LEU THR VAL VAL THR GLN PHE LYS PRO SER GLY ALA SEQRES 24 A 434 ILE ASN ARG TYR TYR VAL GLN ASN GLY VAL THR PHE GLN SEQRES 25 A 434 GLN PRO ASN ALA GLU LEU GLY SER TYR SER GLY ASN GLU SEQRES 26 A 434 LEU ASN ASP ASP TYR CYS TYR ALA GLU GLU ALA GLU PHE SEQRES 27 A 434 GLY GLY SER SER PHE SER ASP LYS GLY GLY LEU THR GLN SEQRES 28 A 434 PHE LYS LYS ALA THR SER GLY GLY MET VAL LEU VAL MET SEQRES 29 A 434 SER LEU TRP ASP ASP TYR TYR ALA ASN MET LEU TRP LEU SEQRES 30 A 434 ASP SER THR TYR PRO THR ASN GLU THR SER SER THR PRO SEQRES 31 A 434 GLY ALA VAL ARG GLY SER CYS SER THR SER SER GLY ASP SEQRES 32 A 434 PRO ALA GLN VAL GLU SER GLN PHE PRO ASN ALA LYS VAL SEQRES 33 A 434 THR PHE SER ASN ILE LYS PHE GLY PRO ILE GLY SER THR SEQRES 34 A 434 GLY ASN PRO SER GLY SEQRES 1 B 434 PCA SER ALA CYS THR LEU GLN PRO GLU THR HIS PRO PRO SEQRES 2 B 434 LEU THR TRP GLN LYS CYS SER SER GLY GLY THR CYS THR SEQRES 3 B 434 GLN GLN THR GLY SER VAL VAL ILE ASP ALA ASN TRP ARG SEQRES 4 B 434 TRP ILE HIS ALA THR ASN SER SER THR SER CYS TYR ASP SEQRES 5 B 434 GLY ASN THR TRP SER SER THR LEU CYS PRO ASP ASN GLU SEQRES 6 B 434 THR CYS THR LYS ASN CYS CYS LEU ASP GLY ALA ALA TYR SEQRES 7 B 434 ALA SER THR TYR GLY VAL THR THR SER GLY ASP SER LEU SEQRES 8 B 434 THR ILE GLY PHE VAL THR GLN SER ALA GLN LYS ASN VAL SEQRES 9 B 434 GLY ALA ARG LEU TYR LEU MET ALA ASN ASP THR THR TYR SEQRES 10 B 434 GLN GLU PHE THR LEU LEU GLY ASN GLU PHE SER PHE ASP SEQRES 11 B 434 VAL ASP VAL SER GLN LEU PRO CYS GLY LEU ASN GLY ALA SEQRES 12 B 434 LEU TYR PHE VAL SER MET ASP ALA ASP GLY GLY VAL SER SEQRES 13 B 434 LYS TYR PRO THR ASN THR ALA GLY ALA LYS TYR GLY THR SEQRES 14 B 434 GLY TYR CYS ASP SER GLN CYS PRO ARG ASP LEU LYS PHE SEQRES 15 B 434 ILE ASN GLY GLN ALA ASN VAL GLU GLY TRP GLU PRO SER SEQRES 16 B 434 THR ASN ASN ALA ASN THR GLY ILE GLY GLY HIS GLY SER SEQRES 17 B 434 CYS CYS SER GLU MET ASP ILE TRP GLU ALA ASN SER ILE SEQRES 18 B 434 SER GLU ALA LEU THR LEU HIS PRO CYS THR THR VAL GLY SEQRES 19 B 434 GLN GLU ILE CYS GLU GLY ASP GLY CYS GLY GLY THR TYR SEQRES 20 B 434 SER LYS ASN ARG TYR GLY GLY PRO CYS ASP PRO ASP GLY SEQRES 21 B 434 CYS ASP TRP ASN PRO TYR ARG LEU GLY ASN THR SER PHE SEQRES 22 B 434 TYR GLY PRO GLY PRO SER PHE THR LEU ASP THR THR LYS SEQRES 23 B 434 LYS LEU THR VAL VAL THR GLN PHE LYS PRO SER GLY ALA SEQRES 24 B 434 ILE ASN ARG TYR TYR VAL GLN ASN GLY VAL THR PHE GLN SEQRES 25 B 434 GLN PRO ASN ALA GLU LEU GLY SER TYR SER GLY ASN GLU SEQRES 26 B 434 LEU ASN ASP ASP TYR CYS TYR ALA GLU GLU ALA GLU PHE SEQRES 27 B 434 GLY GLY SER SER PHE SER ASP LYS GLY GLY LEU THR GLN SEQRES 28 B 434 PHE LYS LYS ALA THR SER GLY GLY MET VAL LEU VAL MET SEQRES 29 B 434 SER LEU TRP ASP ASP TYR TYR ALA ASN MET LEU TRP LEU SEQRES 30 B 434 ASP SER THR TYR PRO THR ASN GLU THR SER SER THR PRO SEQRES 31 B 434 GLY ALA VAL ARG GLY SER CYS SER THR SER SER GLY ASP SEQRES 32 B 434 PRO ALA GLN VAL GLU SER GLN PHE PRO ASN ALA LYS VAL SEQRES 33 B 434 THR PHE SER ASN ILE LYS PHE GLY PRO ILE GLY SER THR SEQRES 34 B 434 GLY ASN PRO SER GLY MODRES 5OA5 PCA A 1 MODIFIED RESIDUE MODRES 5OA5 PCA B 1 MODIFIED RESIDUE HET PCA A 1 8 HET PCA B 1 8 HET NAG A 501 14 HET NAG A 502 14 HET NAG A 503 14 HET NAG B 501 14 HET NAG B 502 14 HET NAG B 503 14 HET GOL B 504 6 HETNAM PCA PYROGLUTAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PCA 2(C5 H7 N O3) FORMUL 3 NAG 6(C8 H15 N O6) FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *546(H2 O) HELIX 1 AA1 ALA A 36 ARG A 39 5 4 HELIX 2 AA2 ASP A 63 ASN A 70 1 8 HELIX 3 AA3 ALA A 77 GLY A 83 1 7 HELIX 4 AA4 ALA A 163 GLY A 168 5 6 HELIX 5 AA5 ASP A 241 GLY A 244 5 4 HELIX 6 AA6 ASN A 327 GLY A 339 1 13 HELIX 7 AA7 SER A 341 LYS A 346 1 6 HELIX 8 AA8 GLY A 347 SER A 357 1 11 HELIX 9 AA9 MET A 374 SER A 379 1 6 HELIX 10 AB1 ASP A 403 PHE A 411 1 9 HELIX 11 AB2 ALA B 36 ARG B 39 5 4 HELIX 12 AB3 ASP B 63 ASN B 70 1 8 HELIX 13 AB4 ALA B 77 GLY B 83 1 7 HELIX 14 AB5 ALA B 163 GLY B 168 5 6 HELIX 15 AB6 ASP B 241 GLY B 244 5 4 HELIX 16 AB7 ASN B 327 GLY B 339 1 13 HELIX 17 AB8 SER B 341 LYS B 346 1 6 HELIX 18 AB9 GLY B 347 SER B 357 1 11 HELIX 19 AC1 MET B 374 SER B 379 1 6 HELIX 20 AC2 ASP B 403 PHE B 411 1 9 SHEET 1 A10 VAL A 309 GLN A 312 0 SHEET 2 A10 ILE A 300 GLN A 306 -1 SHEET 3 A10 LEU A 288 PHE A 294 -1 SHEET 4 A10 ASN A 125 VAL A 131 -1 SHEET 5 A10 LYS A 422 PRO A 425 -1 SHEET 6 A10 PRO A 13 CYS A 19 1 SHEET 7 A10 CYS A 25 ILE A 34 -1 SHEET 8 A10 ALA A 106 MET A 111 -1 SHEET 9 A10 VAL A 361 TRP A 367 -1 SHEET 10 A10 ASN A 141 VAL A 147 -1 SHEET 1 B 2 ILE A 41 ALA A 43 0 SHEET 2 B 2 CYS A 71 LEU A 73 -1 SHEET 1 C 4 VAL A 84 SER A 87 0 SHEET 2 C 4 SER A 90 GLY A 94 -1 SHEET 3 C 4 LYS A 415 SER A 419 -1 SHEET 4 C 4 ASP A 130 ASP A 132 -1 SHEET 1 D 2 VAL A 96 GLN A 98 0 SHEET 2 D 2 LYS A 102 VAL A 104 -1 SHEET 1 E 2 GLU A 119 THR A 121 0 SHEET 2 E 2 GLY A 359 VAL A 361 -1 SHEET 1 F 2 HIS A 206 CYS A 209 0 SHEET 2 F 2 GLU A 236 GLU A 239 -1 SHEET 1 G 3 GLU A 212 ASP A 214 0 SHEET 2 G 3 LEU A 225 HIS A 228 -1 SHEET 3 G 3 CYS A 261 TRP A 263 -1 SHEET 1 H 2 ALA A 316 LEU A 318 0 SHEET 2 H 2 TYR A 321 GLY A 323 -1 SHEET 1 I10 VAL B 309 GLN B 312 0 SHEET 2 I10 ILE B 300 GLN B 306 -1 SHEET 3 I10 LEU B 288 PHE B 294 -1 SHEET 4 I10 ASN B 125 VAL B 131 -1 SHEET 5 I10 LYS B 422 PRO B 425 -1 SHEET 6 I10 PRO B 12 CYS B 19 1 SHEET 7 I10 CYS B 25 ILE B 34 -1 SHEET 8 I10 ALA B 106 MET B 111 -1 SHEET 9 I10 VAL B 361 TRP B 367 -1 SHEET 10 I10 ASN B 141 VAL B 147 -1 SHEET 1 J 2 ILE B 41 ALA B 43 0 SHEET 2 J 2 CYS B 71 LEU B 73 -1 SHEET 1 K 4 VAL B 84 SER B 87 0 SHEET 2 K 4 SER B 90 GLY B 94 -1 SHEET 3 K 4 LYS B 415 SER B 419 -1 SHEET 4 K 4 ASP B 130 ASP B 132 -1 SHEET 1 L 2 VAL B 96 GLN B 98 0 SHEET 2 L 2 LYS B 102 VAL B 104 -1 SHEET 1 M 2 GLU B 119 THR B 121 0 SHEET 2 M 2 GLY B 359 VAL B 361 -1 SHEET 1 N 2 HIS B 206 CYS B 209 0 SHEET 2 N 2 GLU B 236 GLU B 239 -1 SHEET 1 O 3 GLU B 212 ASP B 214 0 SHEET 2 O 3 LEU B 225 HIS B 228 -1 SHEET 3 O 3 CYS B 261 TRP B 263 -1 SHEET 1 P 2 ALA B 316 LEU B 318 0 SHEET 2 P 2 TYR B 321 GLY B 323 -1 SSBOND 1 CYS A 4 CYS A 72 1555 1555 2.06 SSBOND 2 CYS A 19 CYS A 25 1555 1555 2.10 SSBOND 3 CYS A 50 CYS A 71 1555 1555 2.02 SSBOND 4 CYS A 61 CYS A 67 1555 1555 2.08 SSBOND 5 CYS A 138 CYS A 397 1555 1555 2.04 SSBOND 6 CYS A 172 CYS A 210 1555 1555 2.07 SSBOND 7 CYS A 176 CYS A 209 1555 1555 2.04 SSBOND 8 CYS A 230 CYS A 256 1555 1555 2.03 SSBOND 9 CYS A 238 CYS A 243 1555 1555 2.04 SSBOND 10 CYS A 261 CYS A 331 1555 1555 2.07 SSBOND 11 CYS B 4 CYS B 72 1555 1555 2.05 SSBOND 12 CYS B 19 CYS B 25 1555 1555 2.09 SSBOND 13 CYS B 50 CYS B 71 1555 1555 2.02 SSBOND 14 CYS B 61 CYS B 67 1555 1555 2.11 SSBOND 15 CYS B 138 CYS B 397 1555 1555 2.05 SSBOND 16 CYS B 172 CYS B 210 1555 1555 2.06 SSBOND 17 CYS B 176 CYS B 209 1555 1555 2.06 SSBOND 18 CYS B 230 CYS B 256 1555 1555 2.07 SSBOND 19 CYS B 238 CYS B 243 1555 1555 2.06 SSBOND 20 CYS B 261 CYS B 331 1555 1555 2.09 LINK C PCA A 1 N SER A 2 1555 1555 1.33 LINK ND2 ASN A 64 C1 NAG A 501 1555 1555 1.45 LINK ND2 ASN A 113 C1 NAG A 502 1555 1555 1.44 LINK ND2 ASN A 270 C1 NAG A 503 1555 1555 1.44 LINK C PCA B 1 N SER B 2 1555 1555 1.32 LINK ND2 ASN B 64 C1 NAG B 501 1555 1555 1.46 LINK ND2 ASN B 113 C1 NAG B 502 1555 1555 1.44 LINK ND2 ASN B 270 C1 NAG B 503 1555 1555 1.44 CISPEP 1 TYR A 381 PRO A 382 0 -1.04 CISPEP 2 TYR B 381 PRO B 382 0 -2.57 CRYST1 102.940 92.100 102.200 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009714 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010858 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009785 0.00000 HETATM 1 N PCA A 1 6.298 -7.209 -45.242 1.00 11.98 N HETATM 2 CA PCA A 1 4.957 -7.772 -45.274 1.00 12.31 C HETATM 3 CB PCA A 1 5.031 -9.028 -44.424 1.00 12.13 C HETATM 4 CG PCA A 1 6.319 -8.872 -43.612 1.00 12.41 C HETATM 5 CD PCA A 1 7.052 -7.741 -44.297 1.00 12.28 C HETATM 6 OE PCA A 1 8.191 -7.386 -43.995 1.00 12.64 O HETATM 7 C PCA A 1 3.983 -6.865 -44.590 1.00 12.56 C HETATM 8 O PCA A 1 4.344 -6.191 -43.622 1.00 12.32 O